[Federal Register Volume 76, Number 75 (Tuesday, April 19, 2011)]
[Notices]
[Page 21906]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-9417]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Intent To Award Affordable Care Act Funding to Approved 
Applications Formerly Received in Response to the Centers for Disease 
Control and Prevention Funding Opportunity IP11-010, ``Enhanced 
Surveillance for New Vaccine Preventable Disease''

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice provides public announcement of CDC's intent to 
fund Approved cooperative agreement applications previously received 
and competed in response to CDC Funding Opportunity, CDC-RFA-IP11-010, 
``Enhanced Surveillance for New Vaccine Preventable Disease.'' It is 
the intent of CDC to fund the applications with Patient Protection 
Affordable Care Act (ACA), Section 4002, appropriations.
    CFDA Number 93.533 is the ACA-specific CFDA number for this 
initiative.

Award Information

    Approximate Current Fiscal Year Funding: $2,750,000.
    Approximate Number of Awards: 3-5.
    Approximate Average Award: $500,000.
    Fiscal Year Funds: Patient Protection and Affordable Health Care 
Act of 2011.
    Anticipated Award Date: 31 May 2011.
    Budget Period: 12 months.
    Project Period: 5 years.
    Application Selection Process: CDC will apply the same selection 
methodology published in the FOA, CDC-RFA-IP11-010.
    The following will be considered in making funding decisions:
     Scientific and technical merit of the proposed project as 
determined by scientific peer review.
     Availability of funds.
     Relevance of the proposed project to program priorities.
     Funding decision criteria will include a priority score, 
programmatic importance/value relative to program priorities, past and 
current surveillance performance and capabilities, research portfolio, 
geographic locations, and study population consideration (ethnicity, 
etc.)
     Preference may be given to a medical institution catchment 
area having a total population of greater than 500,000 persons.
     Applicants must have a letter of support with a research 
laboratory for rotavirus analyses or they will not be funded.
    CDC will add the following Authority to that which is reflected in 
the published Funding Opportunity:

--Section 4002 of the Patient Protection and Affordable Care Act 
(Public Law 111-148.)

DATES: The effective date for this action is April 19, 2011 and remains 
in effect until the expiration of the project period of the ACA funded 
applications..

FOR FURTHER INFORMATION CONTACT: Elmira Benson, Deputy Director, 
Centers for Disease Control and Prevention, 2920 Brandywine Road, 
Atlanta, GA 30341, telephone (770) 488-2802, e-mail 
[email protected].

SUPPLEMENTARY INFORMATION: On March 23, 2010, the President signed into 
law the Patient Protection and Affordable Care Act (ACA). ACA is 
designed to improve and expand the scope of health care coverage for 
Americans. Cost savings through disease prevention is an important 
element of this legislation and ACA has established a Prevention and 
Public Health Fund (PPHF) for this purpose. Specifically, the 
legislation states in Section 4002 that the PPHF is to ``provide for 
expanded and sustained national investment in prevention and public 
health programs to improve health and help restrain the rate of growth 
in private and public sector health care costs. ACA and the Prevention 
and Public Health Fund make improving public health a priority with 
investments to improve public health.
    The PPHF states that the Secretary shall transfer amounts in the 
Fund to accounts within the Department of Health and Human Services to 
increase funding, over the fiscal year 2008 level, for programs 
authorized by the Public Health Services Act, for prevention, wellness 
and public health activities including prevention research and health 
screenings, such as the Community Transformation Grant Program, the 
Education and Outreach Campaign for Preventative Benefits, and 
Immunization Programs.
    ACA legislation affords an important opportunity to advance public 
health across the lifespan and to reduce health disparities by 
supporting an intensive community approach to chronic disease 
prevention and control.
    Therefore, the FOA program activities CDC proposes to fund with ACA 
appropriations are authorized by the amendment to the Public Health 
Services Act which authorized the Prevention and Wellness Program.

    Dated: April 8, 2011.
John Murphy,
Business Operation Manager, Centers for Disease Control and Prevention.
[FR Doc. 2011-9417 Filed 4-18-11; 8:45 am]
BILLING CODE 4163-18-P